{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T12:40:10Z","timestamp":1743943210433,"version":"3.40.3"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["FP-HEALTH-2007-2.4.4-1 2005,15"],"award-info":[{"award-number":["FP-HEALTH-2007-2.4.4-1 2005,15"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GN0970"],"award-info":[{"award-number":["01GN0970"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1038\/jid.2011.465","type":"journal-article","created":{"date-parts":[[2012,2,13]],"date-time":"2012-02-13T06:07:28Z","timestamp":1329113248000},"page":"508-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["The Three Dimensions of Functional T-Cell Tolerance: From Research to Practice"],"prefix":"10.1016","volume":"132","author":[{"given":"Christian","family":"H\u00fcnefeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Mezger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"R\u00f6cken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"R\u00f6cken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2011.465_bb0010","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ni725","article-title":"IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB\/c mice","volume":"2","author":"Biedermann","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1038\/jid.2011.465_bb0015","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/80516","article-title":"Encephalitogenic potential of the myelin basic protein peptide (amino acids 83\u201399) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand","volume":"10","author":"Bielekova","year":"2000","journal-title":"Nat Med"},{"key":"10.1038\/jid.2011.465_bb0020","first-page":"1515","article-title":"Eradication of disseminated lymphomas with CpG-DNA activated T helper type 1 cells from nontransgenic mice","volume":"60","author":"Egeter","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2011.465_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clim.2011.05.007","article-title":"Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency","volume":"141","author":"Felgentreff","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1038\/jid.2011.465_bb0030","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/jid.2010.111","article-title":"From cell signaling to novel therapeutic concepts: international pemphigus meeting on advances in pemphigus research and therapy","volume":"130","author":"Getsios","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.465_bb0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nm804","article-title":"Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease","volume":"9","author":"Ghoreschi","year":"2003","journal-title":"Nat Med"},{"key":"10.1038\/jid.2011.465_bb0040","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1084\/jem.20100977","article-title":"Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells","volume":"208","author":"Ghoreschi","year":"2011","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2011.465_bb0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"10.1038\/jid.2011.465_bb0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJMoa0810652","article-title":"Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis","volume":"362","author":"Griffiths","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2011.465_bb0055","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.4049\/jimmunol.0900793","article-title":"Self-peptides prolong survival in murine autoimmunity via reduced IL-2\/IL-7-mediated STAT5 signaling, CD8 coreceptor, and Valpha2 down-regulation","volume":"183","author":"Gutermuth","year":"2009","journal-title":"J Immunol"},{"key":"10.1038\/jid.2011.465_bb0060","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.2557","article-title":"ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression","volume":"18","author":"Hoetzenecker","year":"2012","journal-title":"Nat Med"},{"key":"10.1038\/jid.2011.465_bb0065","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1056\/NEJMoa0800251","article-title":"Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1","volume":"358","author":"Hunder","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2011.465_bb0070","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(08)61619-0","article-title":"Efficacy and safety of oral fumarate in patients with relapsing\u2013remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study","volume":"372","author":"Kappos","year":"2008","journal-title":"Lancet"},{"key":"10.1038\/jid.2011.465_bb0075","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","article-title":"Autoinflammatory diease reloaded: a clinical perspective","volume":"140","author":"Kastner","year":"2010","journal-title":"Cell"},{"key":"10.1038\/jid.2011.465_bb0080","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/333742a0","article-title":"Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes","volume":"333","author":"Kisielow","year":"1988","journal-title":"Nature"},{"key":"10.1038\/jid.2011.465_bb0085","doi-asserted-by":"crossref","first-page":"15074","DOI":"10.1073\/pnas.96.26.15074","article-title":"Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy","volume":"96","author":"Kwon","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2011.465_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.20061852","article-title":"Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease","volume":"204","author":"Lahl","year":"2007","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2011.465_bb0095","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1523-1747.2001.01363.x","article-title":"HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA\/MART1","volume":"116","author":"Lang","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.465_bb0100","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/jid.2011.465_bb0105","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/362758a0","article-title":"Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells","volume":"362","author":"Moskophidis","year":"1993","journal-title":"Nature"},{"key":"10.1038\/jid.2011.465_bb0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ccr.2008.04.001","article-title":"TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis","volume":"13","author":"M\u00fcller-Hermelink","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1038\/jid.2011.465_bb0115","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2011.347","article-title":"Soluble peptide treatment reverses CD8 T-cell-induced disease in a mouse model of spontaneous tissue-selective autoimmunity","volume":"132","author":"Paek","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.465_bb0120","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1084\/jem.180.5.1961","article-title":"Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease","volume":"180","author":"Racke","year":"1994","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2011.465_bb0125","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.tibtech.2007.07.009","article-title":"Stem cells in veterinary medicine\u2014attempts at regenerating equine tendon after injury","volume":"25","author":"Richardson","year":"2007","journal-title":"Trends Biotechnol"},{"key":"10.1038\/jid.2011.465_bb0130","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","article-title":"Ipilimumab plus dacarbazine for previously untreated metastatic melanoma","volume":"364","author":"Robert","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2011.465_bb0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/359079a0","article-title":"Infection breaks T-cell tolerance","volume":"359","author":"Rcken","year":"1992","journal-title":"Nature"},{"key":"10.1038\/jid.2011.465_bb0140","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1084\/jem.179.6.1885","article-title":"Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivo","volume":"179","author":"Urban","year":"1994","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2011.465_bb0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1084\/jem.171.1.115","article-title":"Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism","volume":"171","author":"Sadick","year":"1990","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2011.465_bb0150","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.coi.2007.08.005","article-title":"The sound of silence: modulating anergy in T lymphocytes","volume":"19","author":"Saibil","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.1038\/jid.2011.465_bb0155","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1038\/jid.2011.465_bb0160","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/08923979309035240","article-title":"Antagonistic effects of endogenous and exogenous TGF-beta and TNF on auto-immune diseases in mice","volume":"15","author":"Santambrogio","year":"1993","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1038\/jid.2011.465_bb0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0092-8674(91)90163-S","article-title":"Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction","volume":"65","author":"Schnrich","year":"1991","journal-title":"Cell"},{"key":"10.1038\/jid.2011.465_bb0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-12-387827-4.00004-8","article-title":"Biological functions of regulatory T cells","volume":"112","author":"Shevach","year":"2011","journal-title":"Adv Immunol"},{"key":"10.1038\/jid.2011.465_bb0175","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1182\/blood-2008-08-175109","article-title":"EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion","volume":"113","author":"Ziegler","year":"2009","journal-title":"Blood"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15356104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15356104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T12:05:47Z","timestamp":1743941147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15356104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0022202X15356104"],"URL":"https:\/\/doi.org\/10.1038\/jid.2011.465","relation":{},"ISSN":["0022-202X"],"issn-type":[{"type":"print","value":"0022-202X"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Three Dimensions of Functional T-Cell Tolerance: From Research to Practice","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2011.465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}